Newsroom Stories

The silkworm moth, whose caterpillars have been used in silk production since antiquity, may have been brought to southern Central Asia 4,000 years ago — nearly 2,000 years earlier than previously assumed — according to new research from WashU.

WashU and Bristol Myers Squibb have formed a multiyear collaboration to advance drug development projects in the neurosciences. WashU medical and research trainees will have opportunities to work alongside the company’s scientists at its facilities as part of the agreement.

Plant scientists at WashU organize research on wild plant diseases that could help agricultural systems endure climate change.

Using machine learning, researchers at WashU Bursky Public Health identified the factors most strongly linked to poor sleep during late pregnancy.

An AI-enabled software tool developed by WashU Medicine researchers is the first device to predict malignant cerebral edema, a dangerous complication of acute stroke.

WashU Medicine researchers have shown in mice that a medication-design technique in which modular components of anti-cancer drugs are administered separately and assembled in the body — using what’s known as “click chemistry” — is more effective than standard treatments at targeting and shrinking tumors.

Biologist Rachel Penczykowski, in WashU Arts & Sciences, is an expert in infectious disease in plants. She conducts much of her research in the field — rural farmland, urban parks and, on this sunny day, a garden bed at Jackson Park Elementary School in the University City School District.

By studying two very different animals, biologist Andreas Kautt in WashU Arts & Sciences is uncovering the genetic changes that help species adapt and diversify.

C-BRAIN, the consortium co-founded by WashU Medicine and directed by neurologist Randall J. Bateman, MD, brings together members from academia, major pharmaceutical companies and philanthropic organizations.

Research led by WashU Medicine neurologist Jorge Llibre-Guerra, MD, provides the first direct evidence that some parts of Latin America are moving in the opposite direction of dropping dementia rates in the U.S. and other wealthy nations.